NCT00195481View on ClinicalTrials.gov

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Kidney FailureGraft vs Host Disease
Interventions
DRUG

Rapamune

Trial Locations (5)

566 006

Bangalore

566 018

Bangalore

Unknown

Saket

New Delhi

600 004

Chennai

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195481 - Study Evaluating Sirolimus in Kidney Transplant Recipients in India | Biotech Hunter | Biotech Hunter